157 related articles for article (PubMed ID: 38578577)
1. Regeneration of Volumetric Muscle Loss Using MSCs Encapsulated in PRP-Derived Fibrin Microbeads.
Şeker Ş; Lalegül-Ülker Ö; Elçin AE; Elçin YM
Methods Mol Biol; 2024 Apr; ():. PubMed ID: 38578577
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of bone marrow-MSCs in PRP-derived fibrin microbeads and preliminary evaluation in a volumetric muscle loss injury rat model: modular muscle tissue engineering.
Lalegül-Ülker Ö; Şeker Ş; Elçin AE; Elçin YM
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):10-21. PubMed ID: 30514127
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation of MSCs in PRP-Derived Fibrin Microbeads.
Lalegül-Ülker Ö; Şeker Ş; Elçin AE; Murat Elçin Y
Methods Mol Biol; 2024; 2736():85-93. PubMed ID: 37219812
[TBL] [Abstract][Full Text] [Related]
4. Skeletal Muscle Tissue Engineering: Biomaterials-Based Strategies for the Treatment of Volumetric Muscle Loss.
Carnes ME; Pins GD
Bioengineering (Basel); 2020 Jul; 7(3):. PubMed ID: 32751847
[TBL] [Abstract][Full Text] [Related]
5. The application of bone marrow mesenchymal stem cells and biomaterials in skeletal muscle regeneration.
Wang YH; Wang DR; Guo YC; Liu JY; Pan J
Regen Ther; 2020 Dec; 15():285-294. PubMed ID: 33426231
[TBL] [Abstract][Full Text] [Related]
6. A Ready-to-Use Purified Exosome Product for Volumetric Muscle Loss and Functional Recovery.
Mazzucchelli L; Sarcon AK; Huang TCT; Li J; Berry CE; Houdek MT; Behfar A; Zhao C; Moran SL
Tissue Eng Part A; 2023 Sep; 29(17-18):481-490. PubMed ID: 37537959
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of fibrin-laminin hydrogel with mesenchymal stem cell spheroids supports skeletal muscle regeneration following trauma.
Genovese P; Patel A; Ziemkiewicz N; Paoli A; Bruns J; Case N; Zustiak SP; Garg K
J Tissue Eng Regen Med; 2021 Dec; 15(12):1131-1143. PubMed ID: 34551191
[TBL] [Abstract][Full Text] [Related]
8. Laminin-111-Enriched Fibrin Hydrogels Enhance Functional Muscle Regeneration Following Trauma.
Ziemkiewicz N; Hilliard GM; Dunn AJ; Madsen J; Haas G; Au J; Genovese PC; Chauvin HM; West C; Paoli A; Garg K
Tissue Eng Part A; 2022 Apr; 28(7-8):297-311. PubMed ID: 34409846
[TBL] [Abstract][Full Text] [Related]
9. The Potential of Combination Therapeutics for More Complete Repair of Volumetric Muscle Loss Injuries: The Role of Exogenous Growth Factors and/or Progenitor Cells in Implantable Skeletal Muscle Tissue Engineering Technologies.
Passipieri JA; Christ GJ
Cells Tissues Organs; 2016; 202(3-4):202-213. PubMed ID: 27825153
[TBL] [Abstract][Full Text] [Related]
10. Keratin Hydrogel Enhances In Vivo Skeletal Muscle Function in a Rat Model of Volumetric Muscle Loss.
Passipieri JA; Baker HB; Siriwardane M; Ellenburg MD; Vadhavkar M; Saul JM; Tomblyn S; Burnett L; Christ GJ
Tissue Eng Part A; 2017 Jun; 23(11-12):556-571. PubMed ID: 28169594
[TBL] [Abstract][Full Text] [Related]
11. Cells, scaffolds, and bioactive factors: Engineering strategies for improving regeneration following volumetric muscle loss.
Eugenis I; Wu D; Rando TA
Biomaterials; 2021 Nov; 278():121173. PubMed ID: 34619561
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation and Biomaterials: Key Players to Repair Volumetric Muscle Loss.
Kiran S; Dwivedi P; Kumar V; Price RL; Singh UP
Cells; 2021 Aug; 10(8):. PubMed ID: 34440785
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Evaluation of Functional Outcomes Following Rat Volumetric Muscle Loss Injury and Repair.
Mintz EL; Passipieri JA; Franklin IR; Toscano VM; Afferton EC; Sharma PR; Christ GJ
Tissue Eng Part A; 2020 Feb; 26(3-4):140-156. PubMed ID: 31578935
[TBL] [Abstract][Full Text] [Related]
14. Platelets in wound healing and regenerative medicine.
Etulain J
Platelets; 2018 Sep; 29(6):556-568. PubMed ID: 29442539
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Approaches for Volumetric Muscle Loss Injury: A Systematic Review and Meta-Analysis.
Greising SM; Corona BT; McGann C; Frankum JK; Warren GL
Tissue Eng Part B Rev; 2019 Dec; 25(6):510-525. PubMed ID: 31578930
[TBL] [Abstract][Full Text] [Related]
16. The Use of Platelet-Rich Plasma in Aesthetic and Regenerative Medicine: A Comprehensive Review.
Samadi P; Sheykhhasan M; Khoshinani HM
Aesthetic Plast Surg; 2019 Jun; 43(3):803-814. PubMed ID: 30552470
[TBL] [Abstract][Full Text] [Related]
17. Platelet-Rich Plasma Therapy in the Treatment of Diseases Associated with Orthopedic Injuries.
Fang J; Wang X; Jiang W; Zhu Y; Hu Y; Zhao Y; Song X; Zhao J; Zhang W; Peng J; Wang Y
Tissue Eng Part B Rev; 2020 Dec; 26(6):571-585. PubMed ID: 32380937
[TBL] [Abstract][Full Text] [Related]
18. Acellular collagen-glycosaminoglycan matrix promotes functional recovery in a rat model of volumetric muscle loss.
Zhu C; Karvar M; Koh DJ; Sklyar K; Endo Y; Quint J; Samandari M; Tamayol A; Sinha I
Regen Med; 2023 Aug; 18(8):623-633. PubMed ID: 37491948
[TBL] [Abstract][Full Text] [Related]
19. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration.
Sassoli C; Vallone L; Tani A; Chellini F; Nosi D; Zecchi-Orlandini S
Cell Tissue Res; 2018 Jun; 372(3):549-570. PubMed ID: 29404727
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review: Adipose-Derived Mesenchymal Stem Cells, Platelet-Rich Plasma and Biomaterials as New Regenerative Strategies in Chronic Skin Wounds and Soft Tissue Defects.
Gentile P; Garcovich S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
